Testing a migraine drug for preventing altitude sickness
Treatments studied
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial investigates whether a medication usually used for migraines (fremanezumab) can help prevent acute mountain sickness in healthy adults who travel to high altitudes. You would receive an injection and be monitored for symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You live at an elevation below 1,000 meters (about 3,280 feet).
- You are generally healthy with no major medical conditions (like heart disease, lung disease, diabetes, or chronic headaches).
- You do not smoke more than 6 cigarettes a day and drink less than 3 alcoholic drinks per day.
- You have not been above 2,000 meters (over 6,500 feet) in the last 8 weeks.
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a traditional Chinese medicine pill (Suxiao Jiuxin Pill) can help prevent acute mountain sickness (the sickness you can get when climbing high mountains). Healthy volunteers who live near sea level will take the pill or a placebo and then go to a high altitude to see if it protects them.
This study tests whether the migraine prevention drug fremanezumab can reduce the number of migraines you get around your period. It is for women who have regular cycles and migraines that are clearly linked to their menstrual period.
This trial tests how acetazolamide affects your body's fluid levels at high altitude. It might help understand if the drug can prevent altitude sickness.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
This trial tests if fremanezumab, a migraine prevention drug, can also reduce the stress and improve the relationship between migraine patients with mild depression and their caregivers. If you or someone you care for has migraines and low mood, this study may help understand how the caregiver is affected.
Hear when a new Acute Mountain Sickness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.